These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8537279)

  • 21. Effect of hyperproduction of TEM-1 beta-lactamase on in vitro susceptibility of Escherichia coli to beta-lactam antibiotics.
    Wu PJ; Shannon K; Phillips I
    Antimicrob Agents Chemother; 1994 Mar; 38(3):494-8. PubMed ID: 8203843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Resistance to amoxicillin and amoxicillin-clavulanic acid combination of 231 clinical strains of Escherichia coli, isolated in 1992 at the Cochin Hospital].
    Bémer-Melchior P; Gilly L; Jugroot-Klotz K; Brun T; Névot P; Paul G
    Pathol Biol (Paris); 1995 Nov; 43(9):760-5. PubMed ID: 8746097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Strain of Escherichia coli resistant to broad-spectrum cephalosporin and amoxicillin/clavulanic acid].
    Martín-Pozo A; Alós JI
    Rev Esp Quimioter; 2012 Sep; 25(3):222-3. PubMed ID: 22987271
    [No Abstract]   [Full Text] [Related]  

  • 24. Emergence of clinical Escherichia coli isolates with decreased susceptibility to ceftazidime and synergic effect with co-amoxiclav due to SHV-1 hyperproduction.
    Miró E; del Cuerpo M; Navarro F; Sabaté M; Mirelis B; Prats G
    J Antimicrob Chemother; 1998 Oct; 42(4):535-8. PubMed ID: 9818756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance to amoxicillin/clavulanate in Escherichia coli.
    Colaert J
    Acta Clin Belg; 1992; 47(5):353-4. PubMed ID: 1334324
    [No Abstract]   [Full Text] [Related]  

  • 26. Resistance to amoxicillin/clavulanate in Escherichia coli.
    Glupczynski Y; Mac Gillavry G; Yourassowsky E
    Acta Clin Belg; 1992; 47(5):354-5. PubMed ID: 1334325
    [No Abstract]   [Full Text] [Related]  

  • 27. In vitro anaerobic data on ticarcillin/clavulanate. A review of an ongoing survey.
    Sanders CV; Aldridge KE
    J Reprod Med; 1990 Mar; 35(3 Suppl):313-6. PubMed ID: 2319513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 beta-lactamase conferring resistance to beta-lactamase inhibitors.
    Zhou XY; Bordon F; Sirot D; Kitzis MD; Gutmann L
    Antimicrob Agents Chemother; 1994 May; 38(5):1085-9. PubMed ID: 8067742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of amoxycillin/clavulanic acid against Escherichia coli in vivo--correction.
    Beale AS
    J Antimicrob Chemother; 1992 Jul; 30(1):108. PubMed ID: 1429330
    [No Abstract]   [Full Text] [Related]  

  • 30. Resistance to beta-lactam/clavulanate.
    Martinez JL; Cercenado E; Rodriguez-Creixems M; Vincente-Perez MF; Delgado-Iribarren A; Baquero F
    Lancet; 1987 Dec; 2(8573):1473. PubMed ID: 2892042
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro activity of mecillinam and amoxicillin/clavulanic acid against strains of Escherichia coli producing TEM-1, Oxa-1 and chromosomal beta-lactamases.
    Marre R; Schulz E
    Arzneimittelforschung; 1988 Jul; 38(7):863-5. PubMed ID: 3061383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An in-vitro and in-vivo comparison of the activity of beta-lactamase inhibitor combinations with imipenem and cephalosporins against Escherichia coli producing TEM-1 or TEM-2 beta-lactamase.
    Cherubin CE; Eng RH; Smith SM; Tan EN
    J Antimicrob Chemother; 1991 Jul; 28(1):61-70. PubMed ID: 1769944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperproduction of TEM-1 beta-lactamase by Escherichia coli strains.
    Page JW; Farmer TH; Elson SW
    J Antimicrob Chemother; 1989 Jan; 23(1):160-1. PubMed ID: 2663805
    [No Abstract]   [Full Text] [Related]  

  • 34. [Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium].
    Leclercq R; Duval J
    Pathol Biol (Paris); 1995 Apr; 43(4):245-52. PubMed ID: 7567109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Appearance of Escherichia coli strain with high production of cephalosporinase during treatment with an amoxicillin and clavulanic acid combination].
    Aubert G; Peyle V; Dumont N; el Fassi M; Dorche G
    Ann Biol Clin (Paris); 1990; 48(7):449-54. PubMed ID: 2278408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A combination of mecillinam and amoxicillin/clavulanate can restore susceptibility of high-level TEM-1-producing Escherichia coli to mecillinam.
    Birgy A; Delecourt M; Geslain G; Desselas E; Caseris M; Magnan M; Mariani-Kurkdjian P; Bidet P; Bonacorsi S
    J Antimicrob Chemother; 2017 Jul; 72(7):1911-1914. PubMed ID: 28369441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Piperacillin tazobactam compared with co-amoxiclav, ampicillin plus sulbactam and timentin against beta-lactamase-producing clinical isolates of Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca.
    Traub WH; Leonhard B
    Chemotherapy; 1995; 41(5):345-52. PubMed ID: 8521736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antimicrobial activities of clavulanic acid/ticarcillin against clinical isolates].
    Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Deguchi K; Oda S; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1995 Dec; 48(12):1899-905. PubMed ID: 8587164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of reduced susceptibility to amoxycillin-clavulanic acid in Escherichia coli strains from the health region of Tortosa (Catalonia, Spain).
    Pérez-Moreno MO; Pérez-Moreno M; Carulla M; Rubio C; Jardí AM; Zaragoza J
    Clin Microbiol Infect; 2004 Mar; 10(3):234-41. PubMed ID: 15008945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests.
    Sanders CC; Iaconis JP; Bodey GP; Samonis G
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1365-9. PubMed ID: 3143303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.